This page shows the latest UK government news and features for those working in and with pharma, biotech and healthcare.
The UK Vaccines Taskforce is also working with CureVac to assess multiple variants of the SARS-CoV-2 virus that causes COVID-19, and will seek to generate vaccine candidates against ... In a statement, the UK government said that ‘almost all
The US government also has the option to purchase an additional 200 million doses under a subsequent agreement. ... The UK government has secured 30 million doses of J&J’s vaccine, which will be supplied on a not-for-profit basis during the emergency
The world’s first COVID-19 human challenge study is set to begin in the UK within the next few weeks after receiving ethics approval, the government has announced. ... The study has already received a £33.6m investment from the UK government, and will
The UK’s Medicines &Healthcare Products Regulatory Agency (MHRA) approved its first vaccine, the Pfizer/BioNTech jab, in December 2020. ... The UK government had been aiming to vaccinate approximately 15 million people by mid-February, with priority to
Tocilizumab was added to the Oxford University-led RECOVERY trial in April, as well as the UK-based REMAP-CAP trial. ... The UK government said that it is ‘working closely’ with Roche to make sure that tocilizumab is available on the NHS for COVID-19
The UK government has announced a partnership with German biopharma company CureVac, which will seek to develop vaccines against new COVID-19 variants. ... In a statement, the UK government added that ‘almost all vaccines’ developed as part of the
More from news
Approximately 13 fully matching, plus 433 partially matching documents found.
The rationale? That behavioural scientists’ influence over the UK government’s COVID response caused a delay in lockdown that cost thousands of lives. ... Similarly, the UK government’s Behavioural Insight Team claims good successes in education,
But the significantly lower rates in France, Germany and the UK show that this is not universally true and remind us that country-by-country variations will be significant. ... homes. Indeed, in the UK it is government that has approached the industry
In the UK, the government relied on its preferred nudge theory to kick-start behaviour change, rather than implementing more draconian measures straight away.
The project is part of the UK government’s five-year, multi-agency action plan that includes improved stewardship to minimise the chances of resistant strains emerging. ... UK Government is serious about fixing the broken market for the long term.
From a UK perspective, the challenge of getting the right antibiotic the first time around is exemplified in the current treatment of urinary tract infections (UTIs). ... We argue that ‘delinking’ strategies like those being trialled by the UK
More from intelligence
Approximately 0 fully matching, plus 54 partially matching documents found.
Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area ... Prior to his time with Pfizer, Maine was
As chief executive, he will primarily work with the board of directors and government organisation Innovate UK to develop and implement a new five-year business plan for the drug discovery ... The Catapult will engage the UK's experienced drug discovery
In his new position, Campbell will drive the development and delivery of the UK government-sponsored agency's life sciences and health sector. ... Dr Ruth McKernan, chief executive of Innovate UK, said: “Ian Campbell will make a strong addition to the
Gates Foundation and at the UK government's department for international development.
Prior to this, Price served as communications and public affairs lead at e-skills UK, working with clients and government policy makers to inform business objectives and strategy.
More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.
The final report of the Independent Review of the Mental Health Act 1983 has been published today, 6th December 2018. The final report of the independent review of the Mental Health Act 1983 ‘Modernising the Mental Health Act’ has been published.
The European Commission and the UK Government Vaccine Taskforce have also been significant contributors to a wide variety of vaccine projects.
Suddenly people were comparing the length of approval processes in the UK, Europe, and the US. ... Unclear and incomplete information fosters distrust. For example, the public unease about the lack of available information around Pfizer’s legal
Worked to speed up access to innovative medicines and technologies, including contributing to the UK Government’s Accelerated Access Review. ... London. EC1V 0LN. UK.
The Government’s 2019 election manifesto pledged to make the UK the leading hub for life sciences. ... But actions speak louder than words and limited NICE reform will be seen as a conscious act of apathy by the UK Government towards the industry.
More from PMHub
Approximately 0 fully matching, plus 22 partially matching documents found.
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...